| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |